The news feeds on this site are independently provided by Adfero Limited © and do not represent the views or opinions of the World Gold Council.

Monday, 15th June 2009 (1065 views)

Gold nanoparticles are being used in a new treatment that could potentially help people with type 1 diabetes, it has been revealed.

Jeff Bulte, professor of Radiology in the School of Medicine and an affiliated faculty member of the Institute for NanoBioTechnology at John Hopkins University, has won financial support for his innovative therapy system.

He has been chosen to receive a $230,000 (£141,107) grant from the Maryland Nanobiotechnology Research and Industry Competition to help carry out the work.

In partnership with Baltimore company Surgivision, he and his colleague Dian Arifin will collaborate on a project to bring the technology to commercialisation.

The process uses gadolium-gold nanoparticles to improve imaging technology, which could help to develop cell therapy for sufferers of type 1 diabetes.

Gold nanoparticles are often used in medical research, such as for cancer treatments and diagnostics, which has been demonstrated in work carried out by the Georgia Institute of Technology and the University of California at San Francisco.

 

« Back to Gold News stories